EVIO (OTCQB:EVIO) announced the execution of a long-term lease for a 2,700 square foot facility in Los Angeles to offer analytical testing services in the Southern California cannabis market.
As quoted in the press release:
Due to California’s July 1sttesting deadline mandating licensed retailers to sell only lab tested product, the company is expecting a significant uptick in the need for testing services. There is a high concentration of distributors planned to operate in the city. This would make L.A. home to the greatest number of legal MMJ and adult-use cannabis businesses of any municipality in the country.
EVIO’s CEO William Waldrop stated, “This is the next step in our mission to expand and meet the demand for our services which is expected to increase significantly as the state rolls out the July 1st state mandated testing deadline. We are focused on positioning EVIO to capitalize on this tremendous growth by pursuing aggressive expansion.”